Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Researchers investigating immune B-cell response to the Epstein-Barr virus (EBV) and cytomegalovirus (CMV) say they have found that it may correlate with the amount of brain-specific B-cells in the...
In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the disease. Certain types of bacteria were either more or less...
A team from the Research Center Hospital of the University of Quebec-Laval say they have found how to neutralize the cells that attack the brain, spine and brain. The study results, published in the...
Patients with neurological conditions are likely to need palliative care near the end of their life, but UK researchers say they have found a wide variation in the coordination of palliative care and...
What if doctors could change your diet and reduce the chances of developing multiple sclerosis? That’s what Brigham and Women’s researchers are suggesting, after discovering the bacteria living in...
The evolution of the myelin sheath throughout childhood has been visualised for a first time, and the findings reported in the study Mapping An Index Of The Myelin G-ratio In Infants Using Magnetic...
‘Rebound syndrome’ following cessation of Gilenya for multiple sclerosis occurs at a clinically relevant rate, shows research, prompting the need for further study on how best to sequence and...
A once-monthly injection for multiple sclerosis from Biogen and AbbVie has been recommended for approval by European regulators, paving the way for its launch in the coming months. The European...
Researchers at the Center of Excellence for Myelin Repair, a part of Mount Sinai, say gut bacteria produces compounds that have been seen to affect the myelin content in mice and cause social...
People with progressive MS make up around half of the UK’s 100,000 MS population, but according to a new report by the MS Trust growing pressures on NHS services mean they get much less support from...

Pages